The answer is No. The fact that your deal avoided a second request investigation does not mean that you are in the clear if your deal substantially lessens competition in a relevant antitrust market. The Department of Justice’s Antitrust Division (“DOJ”) and Federal Trade Commission (“FTC”) have for years emphasized that they will investigate and…
Continue reading ›Antitrust Lawyer Blog
On September 21, 2017, the DOJ’s Antitrust Division issued a business letter stating that it would not challenge a proposal by The Clearing House Payments Company LLC (“TCH”), a joint venture of 24 U.S. banks, to create and operate a new payment system that will enable the real-time transfer of funds between depository institutions, at…
Continue reading ›On September 19, 2017, Valero Corporation (“Valero”) abandoned its acquisition of two northern California bulk petroleum terminals from Plains All American Pipeline (“Plains”) after the California state attorney general filed a lawsuit in the Northern District of California against Valero’s proposed acquisition. The lawsuit was filed on July 8, 2017, a day after the FTC…
Continue reading ›On August 30, 2017, the Federal Trade Commission (“FTC”) announced that Mars, Incorporated (“Mars”) agreed to divest 12 specialty or off-hours emergency animal hospitals around the United States to settle FTC allegations that Mars’s $9.1 billion acquisition of pet care company VCA Inc. (“VCA”) would violate federal antitrust laws. Competition Problem The animal hospital industry…
Continue reading ›On August 23, 2017, the Federal Trade Commission cleared Amazon.com Inc.’s acquisition of Whole Foods Market Inc. without a second request investigation. As mega mergers go, this antitrust review was fast and furious. When the deal was announced, consumer groups and politicians questioned whether the combination was anticompetitive. Even President Trump, during the campaign, had…
Continue reading ›On June 22, 2017, the Federal Trade Commission and the Attorney General of North Dakota filed a complaint to block Sanford Health’s proposed acquisition of Mid Dakota Clinic, seeking a temporary restraining order and preliminary injunction to stop the deal and to maintain the status quo pending an administrative trial on the merits of the…
Continue reading ›On June 19, 2017, the Trump Administration’s Federal Trade Commission (“FTC”) authorized the staff to file an antitrust complaint to block the merger of DraftKings and FanDuel, the two largest daily fantasy sports (“DFS”) sites. The state of California and the District of Columbia Attorneys General joined in the lawsuit. The FTC’s legal challenge is…
Continue reading ›On April 5, 2017, the EC approved China National Chemical Corporation’s (“ChemChina”) proposed acquisition of Syngenta AG (“Syngenta). The approval is conditional on the divestiture of significant parts of ChemChina’s European pesticide and plant growth regulator business. Syngenta is the leading pesticide supplier worldwide. ChemChina is currently active in pesticide markets in Europe through Adama,…
Continue reading ›On April 4, 2017, the FTC entered into a settlement agreement with China National Chemical Corporation (“ChemChina”) and Syngenta AG whereby the parties agreed to divest three types of pesticides, in order to resolve antitrust concerns with its merger. Syngenta is the leading pesticide supplier worldwide. ChemChina is currently active in pesticide markets in the…
Continue reading ›On April 3, 2017, the Department of Justice (“DOJ”) announced that that it forced Danone to divest its Stonyfield Farms business in order for Danone to proceed with its $12.5 billion acquisition of WhiteWave. Prior to the merger, Danone did not produce or sell organic milk in the United States, however, it produced and sold…
Continue reading ›